TNF and glioblastoma: A particularly promising novel therapeutic approach for GBM is the reactivation of apoptosis by treatment with members of the tumor necrosis factor (TNF) family, of which the TNF-related apoptosis-inducing ligand (TRAIL) holds the greatest appeal [2].